(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Combinatorial chemistry in conjunction with High Throughput Screening
(HTS) is revolutionizing the drug discovery process. Yet, we have much
to learn about the integration of these powerful techniques with
information from genomics, proteomics, computation and pharmacokinetics
before dramatic increases in the drug discovery/development processes
can be achieved. The chapters in this book represent the state of the
art regarding the integration of combinatorial chemistry and HTS in
connection with anti-inflammatory targets. Obviously, there is much work
to be done beyond what is described in this text, nevertheless, it
should set the stage for creative thinking among scientists of many
disciplines for the accomplishment of our ultimate goals in treating
inflammatory diseases.
Contents:
Solid phase synthesis: Applications to combinatorial libraries.- Proteasome inhibitors.- Caspase-1 (ICE) and other caspases as drug discovery targets: Opportunities and progress.- Elastase inhibitors.- A high throughput assay for the TNF converting enzyme.- Tryptase inhibitors.- Selectin antagonists.- Cell adhesion integrins as pharmaceutical targets.- Inhibitors of the MAPK pathway.- Inhibition of NF-?B.- IL-1 antagonist discovery.- Phosphodiesterase inhibitors for respiratory diseases.
PRODUCT DETAILS
Publisher: Springer (Birkhauser Verlag AG)
Publication date: November, 2012
Pages: 258
Weight: 421g
Availability: Available
Subcategories: General Issues, Pharmacology
From the same series
